David Kazaishvili MD.

• 1993 – Tbilisi State Medical Institute. Department of General Medicine.

• 1994-1999 – Acad. P. Sarajishvili Institute of Clinical and Experimental Neurology. Department of Anesthesiology – Intensive Care. Anesthesiologist-Reanimatologist;
• 1995-1999 – Department of Neurosurgery of the Republican Central Clinical Hospital, doctor of the intensive care unit;
• 1999-2007 – Neurosurgery Center LLC, anesthesiologist, Head of the Department of Anesthesiology-Resuscitation;
• 2007-2011 – Tbilisi 1^st Clinical Hospital, Head of the Department of Anesthesiology – Intensive Care at the Neurosurgery Center of the University Hospital;
• 2011-2017 – High Medical Technologies Center LLC, University Clinic. Head of the Department of Anesthesiology, Intensive Care and Critical Medicine;
• Medical Director and Head of the Department of Anesthesiology, Intensive Care and Critical Medicine of Gormedi LLC;
• 2019 – 2021 – Medical Director and Head of the Department of Anesthesiology, Intensive Care and Critical Medicine of Jerarsi Clinic;
• 2002-present – Invited teacher at TSMU.
• Since 2021 -till now – Head of the Department of Anesthesiology, Intensive Care and Critical Medicine of High Technology Medical Center, University Clinic.

• 2001 – Anesthesiology – intensive care;
• 2003 – Critical medicine;
• 2000 – Principles for the treatment of severe traumatic brain injury, Moscow;
• 2002 – Brain death and organ transplantation, Tbilisi;
• 2003 – Photodynamic diagnostics and modern aspects of treatment, Tbilisi;
• 2005 – Disaster management, Tbilisi;
• 2008 – Recovery from severe traumatic brain injury, Moscow;
• 2009 – Congress on minimally invasive neurological therapy, Nice;
• 2010 – Effective adult learning methods, Tbilisi;
• 2012 – Pediatric anesthesiology and critical medicine;
• 2017 – Clinical manager.

• School of Anesthesiology and Intensive Care – Co-Founder;
• Geoanesthesia – Co-Organizer and member of the scientific board;
• Since 2012 – Member of the European Society of Intensive Care Medicine (ESICM).

• CRASH-1 use of methylprednisolone in severe traumatic brain injuries;
• CRASH-2 use of tranexamic acid in bleeding caused by acute injuries;
• CRASH-3 use of tranexamic acid in bleeding caused by acute brain injuries;
• TR701FA phase III randomized, double-blind study, comparison of linezolid in case of ventilated gram-positive nosocomial pneumonia;
• Phase III study prospective, randomized, double-blind, multicenter study to compare the safety and efficacy of intravenous ceftolozane-tazobactam with meropenem in adult patients with nosocomial ventilation pneumonia;
• Phase III prospective, randomized, double-blind, multicenter study, anti-staphylococcal antibody-based treatment (current) of ventilator-associated pneumonia caused by st. Aureus.

Publications and Works:

• Author of 11 published works.

Georgian – Native
Russian – Fluent
English – Good